Prosensa Investors Urge Redo On Suit Over Failed Drug
Shareholders of Dutch biotech outfit Prosensa Holding NV urged a New York federal judge Thursday to trigger a reconsideration of their securities class action's dismissal in order to "prevent manifest injustice"...To view the full article, register now.
Already a subscriber? Click here to view full article